nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—Cellular responses to stress—EED—peripheral nervous system neoplasm	0.0229	0.0785	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	0.0183	0.0628	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—RASSF5—peripheral nervous system neoplasm	0.0139	0.0478	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—RASSF5—peripheral nervous system neoplasm	0.0117	0.0401	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	0.00804	0.0275	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—IFNB1—peripheral nervous system neoplasm	0.00723	0.0247	CbGpPWpGaD
Auranofin—IKBKB—TRAIL signaling pathway—TNFSF10—peripheral nervous system neoplasm	0.00705	0.0241	CbGpPWpGaD
Auranofin—IKBKB—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.00586	0.02	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.00374	0.0128	CbGpPWpGaD
Auranofin—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.00347	0.0049	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.00343	0.00485	CcSEcCtD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00341	0.0117	CbGpPWpGaD
Auranofin—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.0034	0.00481	CcSEcCtD
Auranofin—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.00336	0.00475	CcSEcCtD
Auranofin—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.00336	0.00475	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00336	0.00474	CcSEcCtD
Auranofin—Alopecia—Topotecan—peripheral nervous system neoplasm	0.0032	0.00453	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—peripheral nervous system neoplasm	0.00319	0.00451	CcSEcCtD
Auranofin—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.00318	0.0045	CcSEcCtD
Auranofin—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00449	CcSEcCtD
Auranofin—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00449	CcSEcCtD
Auranofin—Alopecia—Melphalan—peripheral nervous system neoplasm	0.00314	0.00443	CcSEcCtD
Auranofin—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00312	0.0044	CcSEcCtD
Auranofin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00308	0.00436	CcSEcCtD
Auranofin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00436	CcSEcCtD
Auranofin—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00435	CcSEcCtD
Auranofin—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.00307	0.00433	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00306	0.00432	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—peripheral nervous system neoplasm	0.00303	0.00427	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.00302	0.0103	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00298	0.0042	CcSEcCtD
Auranofin—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00297	0.00419	CcSEcCtD
Auranofin—Stomatitis—Alitretinoin—peripheral nervous system neoplasm	0.00296	0.00418	CcSEcCtD
Auranofin—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00295	0.00417	CcSEcCtD
Auranofin—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00292	0.00412	CcSEcCtD
Auranofin—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00409	CcSEcCtD
Auranofin—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.00289	0.00409	CcSEcCtD
Auranofin—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.00289	0.00409	CcSEcCtD
Auranofin—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00288	0.00407	CcSEcCtD
Auranofin—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.00287	0.00405	CcSEcCtD
Auranofin—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00286	0.00403	CcSEcCtD
Auranofin—Stomatitis—Vincristine—peripheral nervous system neoplasm	0.00285	0.00403	CcSEcCtD
Auranofin—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.004	CcSEcCtD
Auranofin—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00282	0.00399	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—peripheral nervous system neoplasm	0.0028	0.00395	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00278	0.00952	CbGpPWpGaD
Auranofin—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00277	0.00391	CcSEcCtD
Auranofin—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.00276	0.00389	CcSEcCtD
Auranofin—IKBKB—Apoptosis—TNFSF10—peripheral nervous system neoplasm	0.00267	0.00915	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFNB1—peripheral nervous system neoplasm	0.00267	0.00912	CbGpPWpGaD
Auranofin—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.00266	0.00375	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—NTRK1—peripheral nervous system neoplasm	0.00265	0.00907	CbGpPWpGaD
Auranofin—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00263	0.00371	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.00367	CcSEcCtD
Auranofin—Glossitis—Epirubicin—peripheral nervous system neoplasm	0.00258	0.00364	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.00256	0.00878	CbGpPWpGaD
Auranofin—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.0036	CcSEcCtD
Auranofin—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.00254	0.00358	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00252	0.00357	CcSEcCtD
Auranofin—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00252	0.00356	CcSEcCtD
Auranofin—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00252	0.00356	CcSEcCtD
Auranofin—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00355	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TNFSF10—peripheral nervous system neoplasm	0.00251	0.00859	CbGpPWpGaD
Auranofin—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.00353	CcSEcCtD
Auranofin—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.0025	0.00353	CcSEcCtD
Auranofin—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00249	0.00351	CcSEcCtD
Auranofin—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00247	0.00349	CcSEcCtD
Auranofin—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00245	0.00347	CcSEcCtD
Auranofin—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00344	CcSEcCtD
Auranofin—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00344	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—BDNF—peripheral nervous system neoplasm	0.00243	0.00831	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00242	0.00829	CbGpPWpGaD
Auranofin—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.0034	CcSEcCtD
Auranofin—Anorexia—Melphalan—peripheral nervous system neoplasm	0.0024	0.0034	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—peripheral nervous system neoplasm	0.00238	0.00337	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00236	0.00334	CcSEcCtD
Auranofin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00234	0.0033	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00232	0.00328	CcSEcCtD
Auranofin—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00232	0.00328	CcSEcCtD
Auranofin—Melaena—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00328	CcSEcCtD
Auranofin—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00231	0.00326	CcSEcCtD
Auranofin—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00231	0.00326	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00229	0.00324	CcSEcCtD
Auranofin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00227	0.0032	CcSEcCtD
Auranofin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00318	CcSEcCtD
Auranofin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00318	CcSEcCtD
Auranofin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00224	0.00316	CcSEcCtD
Auranofin—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00224	0.00316	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00315	CcSEcCtD
Auranofin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00222	0.00314	CcSEcCtD
Auranofin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00222	0.00314	CcSEcCtD
Auranofin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00222	0.00314	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00221	0.00312	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—NF1—peripheral nervous system neoplasm	0.00221	0.00755	CbGpPWpGaD
Auranofin—Constipation—Topotecan—peripheral nervous system neoplasm	0.0022	0.00311	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IFNB1—peripheral nervous system neoplasm	0.00219	0.00751	CbGpPWpGaD
Auranofin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.0031	CcSEcCtD
Auranofin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00219	0.0031	CcSEcCtD
Auranofin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00218	0.00309	CcSEcCtD
Auranofin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00218	0.00309	CcSEcCtD
Auranofin—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00217	0.00307	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—BIRC5—peripheral nervous system neoplasm	0.00216	0.00739	CbGpPWpGaD
Auranofin—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00303	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—PPP3R1—peripheral nervous system neoplasm	0.00212	0.00727	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00212	0.00727	CbGpPWpGaD
Auranofin—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00211	0.00298	CcSEcCtD
Auranofin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00211	0.00298	CcSEcCtD
Auranofin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00209	0.00295	CcSEcCtD
Auranofin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00209	0.00295	CcSEcCtD
Auranofin—IKBKB—FAS (CD95) signaling pathway—CASP3—peripheral nervous system neoplasm	0.00209	0.00714	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TP53—peripheral nervous system neoplasm	0.00208	0.00713	CbGpPWpGaD
Auranofin—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.00291	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00206	0.00704	CbGpPWpGaD
Auranofin—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00205	0.0029	CcSEcCtD
Auranofin—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00205	0.00289	CcSEcCtD
Auranofin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00205	0.00289	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00204	0.00289	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PPP3R1—peripheral nervous system neoplasm	0.00204	0.00697	CbGpPWpGaD
Auranofin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00204	0.00288	CcSEcCtD
Auranofin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00287	CcSEcCtD
Auranofin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00287	CcSEcCtD
Auranofin—IKBKB—IL-1 signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00203	0.00694	CbGpPWpGaD
Auranofin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00285	CcSEcCtD
Auranofin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00285	CcSEcCtD
Auranofin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.002	0.00283	CcSEcCtD
Auranofin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00281	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00199	0.00281	CcSEcCtD
Auranofin—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00199	0.00281	CcSEcCtD
Auranofin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00268	CcSEcCtD
Auranofin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00188	0.00266	CcSEcCtD
Auranofin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00264	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—PTPN11—peripheral nervous system neoplasm	0.00186	0.00638	CbGpPWpGaD
Auranofin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00261	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00258	CcSEcCtD
Auranofin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00183	0.00258	CcSEcCtD
Auranofin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00182	0.00257	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00256	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00181	0.00256	CcSEcCtD
Auranofin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00181	0.00256	CcSEcCtD
Auranofin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00181	0.00255	CcSEcCtD
Auranofin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00181	0.00255	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.0018	0.00618	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.0018	0.00617	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—BIRC5—peripheral nervous system neoplasm	0.0018	0.00616	CbGpPWpGaD
Auranofin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00178	0.00252	CcSEcCtD
Auranofin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00178	0.00251	CcSEcCtD
Auranofin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00176	0.00249	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—PTPN11—peripheral nervous system neoplasm	0.00175	0.00599	CbGpPWpGaD
Auranofin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.00247	CcSEcCtD
Auranofin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00175	0.00247	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—PTPN11—peripheral nervous system neoplasm	0.00173	0.00592	CbGpPWpGaD
Auranofin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00173	0.00244	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00244	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IFNB1—peripheral nervous system neoplasm	0.00171	0.00587	CbGpPWpGaD
Auranofin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00171	0.00242	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00241	CcSEcCtD
Auranofin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00241	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.0017	0.00582	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00239	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—BIRC5—peripheral nervous system neoplasm	0.00169	0.00578	CbGpPWpGaD
Auranofin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00238	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—NRAS—peripheral nervous system neoplasm	0.00167	0.00573	CbGpPWpGaD
Auranofin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00166	0.00234	CcSEcCtD
Auranofin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00234	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00233	CcSEcCtD
Auranofin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00164	0.00231	CcSEcCtD
Auranofin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00229	CcSEcCtD
Auranofin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00229	CcSEcCtD
Auranofin—Rash—Topotecan—peripheral nervous system neoplasm	0.00162	0.00229	CcSEcCtD
Auranofin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00162	0.00229	CcSEcCtD
Auranofin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00162	0.00229	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—HGF—peripheral nervous system neoplasm	0.00162	0.00554	CbGpPWpGaD
Auranofin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00228	CcSEcCtD
Auranofin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00228	CcSEcCtD
Auranofin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00228	CcSEcCtD
Auranofin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00227	CcSEcCtD
Auranofin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00227	CcSEcCtD
Auranofin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.0016	0.00227	CcSEcCtD
Auranofin—Constipation—Vincristine—peripheral nervous system neoplasm	0.0016	0.00225	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00225	CcSEcCtD
Auranofin—Rash—Melphalan—peripheral nervous system neoplasm	0.00159	0.00225	CcSEcCtD
Auranofin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00159	0.00224	CcSEcCtD
Auranofin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00224	CcSEcCtD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—PTPN11—peripheral nervous system neoplasm	0.00158	0.00541	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00158	0.00541	CbGpPWpGaD
Auranofin—IKBKB—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.00158	0.00541	CbGpPWpGaD
Auranofin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00222	CcSEcCtD
Auranofin—IKBKB—Insulin Signaling—SLC2A1—peripheral nervous system neoplasm	0.00154	0.00528	CbGpPWpGaD
Auranofin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00217	CcSEcCtD
Auranofin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Auranofin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Auranofin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Auranofin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00152	0.00214	CcSEcCtD
Auranofin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.00214	CcSEcCtD
Auranofin—Nausea—Melphalan—peripheral nervous system neoplasm	0.0015	0.00212	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00149	0.0021	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00148	0.00209	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00208	CcSEcCtD
Auranofin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00147	0.00208	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.00147	0.00504	CbGpPWpGaD
Auranofin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00144	0.00204	CcSEcCtD
Auranofin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00203	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—PTPN11—peripheral nervous system neoplasm	0.00143	0.0049	CbGpPWpGaD
Auranofin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00143	0.00202	CcSEcCtD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—PTPN11—peripheral nervous system neoplasm	0.00142	0.00485	CbGpPWpGaD
Auranofin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00141	0.002	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—peripheral nervous system neoplasm	0.00141	0.00482	CbGpPWpGaD
Auranofin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00197	CcSEcCtD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—PTPN11—peripheral nervous system neoplasm	0.00139	0.00476	CbGpPWpGaD
Auranofin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00195	CcSEcCtD
Auranofin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00194	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—peripheral nervous system neoplasm	0.00137	0.00468	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00137	0.00468	CbGpPWpGaD
Auranofin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00193	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00135	0.0019	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.00135	0.00461	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—PTPN11—peripheral nervous system neoplasm	0.00134	0.0046	CbGpPWpGaD
Auranofin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00133	0.00188	CcSEcCtD
Auranofin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00187	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—PTPN11—peripheral nervous system neoplasm	0.00132	0.00452	CbGpPWpGaD
Auranofin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00132	0.00186	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00131	0.00186	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00185	CcSEcCtD
Auranofin—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.00131	0.00447	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.0013	0.00184	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—NTRK1—peripheral nervous system neoplasm	0.0013	0.00445	CbGpPWpGaD
Auranofin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00183	CcSEcCtD
Auranofin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00183	CcSEcCtD
Auranofin—Constipation—Etoposide—peripheral nervous system neoplasm	0.00129	0.00183	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00182	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00182	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00129	0.00441	CbGpPWpGaD
Auranofin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00128	0.0018	CcSEcCtD
Auranofin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00179	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—PTPN11—peripheral nervous system neoplasm	0.00127	0.00433	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.00126	0.0043	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—peripheral nervous system neoplasm	0.00125	0.0043	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.00125	0.00428	CbGpPWpGaD
Auranofin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00176	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NCAM1—peripheral nervous system neoplasm	0.00125	0.00427	CbGpPWpGaD
Auranofin—IKBKB—IL17 signaling pathway—AKT1—peripheral nervous system neoplasm	0.00124	0.00426	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00124	0.00426	CbGpPWpGaD
Auranofin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00175	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00175	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00124	0.00175	CcSEcCtD
Auranofin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00174	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—peripheral nervous system neoplasm	0.00122	0.00419	CbGpPWpGaD
Auranofin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00172	CcSEcCtD
Auranofin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00172	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP3—peripheral nervous system neoplasm	0.00121	0.00415	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0017	CcSEcCtD
Auranofin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0012	0.0017	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00169	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00169	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00119	0.00169	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00169	CcSEcCtD
Auranofin—IKBKB—Apoptosis—CDKN2A—peripheral nervous system neoplasm	0.00119	0.00408	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BDNF—peripheral nervous system neoplasm	0.00119	0.00408	CbGpPWpGaD
Auranofin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00119	0.00168	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—PTPN11—peripheral nervous system neoplasm	0.00118	0.00404	CbGpPWpGaD
Auranofin—Rash—Vincristine—peripheral nervous system neoplasm	0.00118	0.00166	CcSEcCtD
Auranofin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00118	0.00166	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00166	CcSEcCtD
Auranofin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00162	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00162	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00162	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—PTPN11—peripheral nervous system neoplasm	0.00114	0.0039	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—AKT1—peripheral nervous system neoplasm	0.00113	0.00387	CbGpPWpGaD
Auranofin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00159	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—peripheral nervous system neoplasm	0.00112	0.00383	CbGpPWpGaD
Auranofin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Auranofin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Auranofin—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00109	0.00372	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD55—peripheral nervous system neoplasm	0.00109	0.00371	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—PTPN11—peripheral nervous system neoplasm	0.00107	0.00367	CbGpPWpGaD
Auranofin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00107	0.00151	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00107	0.00365	CbGpPWpGaD
Auranofin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.0015	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—CASP3—peripheral nervous system neoplasm	0.00106	0.00361	CbGpPWpGaD
Auranofin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00149	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—peripheral nervous system neoplasm	0.00105	0.0036	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—NRAS—peripheral nervous system neoplasm	0.00105	0.0036	CbGpPWpGaD
Auranofin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00148	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—NTRK2—peripheral nervous system neoplasm	0.00104	0.00357	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—peripheral nervous system neoplasm	0.00104	0.00356	CbGpPWpGaD
Auranofin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00147	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00147	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00104	0.00355	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP3—peripheral nervous system neoplasm	0.00104	0.00355	CbGpPWpGaD
Auranofin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00146	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00146	CcSEcCtD
Auranofin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00145	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00144	CcSEcCtD
Auranofin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00098	0.00138	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNB1—peripheral nervous system neoplasm	0.000978	0.00335	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000976	0.00334	CbGpPWpGaD
Auranofin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000975	0.00138	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP3—peripheral nervous system neoplasm	0.000971	0.00333	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—peripheral nervous system neoplasm	0.000969	0.00332	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000963	0.0033	CbGpPWpGaD
Auranofin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000961	0.00136	CcSEcCtD
Auranofin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000959	0.00136	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000954	0.00327	CbGpPWpGaD
Auranofin—Rash—Etoposide—peripheral nervous system neoplasm	0.000953	0.00135	CcSEcCtD
Auranofin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000952	0.00134	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000946	0.00134	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000941	0.00322	CbGpPWpGaD
Auranofin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000941	0.00133	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000938	0.00321	CbGpPWpGaD
Auranofin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000929	0.00131	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—peripheral nervous system neoplasm	0.000918	0.00314	CbGpPWpGaD
Auranofin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000898	0.00127	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000888	0.00125	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—AKT1—peripheral nervous system neoplasm	0.000863	0.00295	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PTPN11—peripheral nervous system neoplasm	0.000862	0.00295	CbGpPWpGaD
Auranofin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.00121	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—NTRK1—peripheral nervous system neoplasm	0.00085	0.00291	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000837	0.00286	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTPN11—peripheral nervous system neoplasm	0.000833	0.00285	CbGpPWpGaD
Auranofin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000829	0.00117	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	0.00082	0.00281	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—peripheral nervous system neoplasm	0.000811	0.00277	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—peripheral nervous system neoplasm	0.000809	0.00277	CbGpPWpGaD
Auranofin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000808	0.00114	CcSEcCtD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000807	0.00276	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000799	0.00273	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—peripheral nervous system neoplasm	0.000796	0.00272	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PTPN11—peripheral nervous system neoplasm	0.000795	0.00272	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000792	0.00271	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.00079	0.0027	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000787	0.00269	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—AKT1—peripheral nervous system neoplasm	0.000787	0.00269	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—AKT1—peripheral nervous system neoplasm	0.000787	0.00269	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—peripheral nervous system neoplasm	0.000777	0.00266	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—peripheral nervous system neoplasm	0.00077	0.00264	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—peripheral nervous system neoplasm	0.00077	0.00264	CbGpPWpGaD
Auranofin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.00108	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—peripheral nervous system neoplasm	0.000761	0.00261	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—peripheral nervous system neoplasm	0.000761	0.00261	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.000755	0.00259	CbGpPWpGaD
Auranofin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.00106	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000746	0.00105	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000736	0.00104	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—PTPN11—peripheral nervous system neoplasm	0.000736	0.00252	CbGpPWpGaD
Auranofin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000724	0.00102	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	0.000724	0.00248	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000721	0.00247	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—NRAS—peripheral nervous system neoplasm	0.00071	0.00243	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000695	0.00238	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000693	0.000979	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00069	0.000975	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.000963	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—AKT1—peripheral nervous system neoplasm	0.00068	0.00233	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.00068	0.00233	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—peripheral nervous system neoplasm	0.00068	0.00233	CbGpPWpGaD
Auranofin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000673	0.000951	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000673	0.0023	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—peripheral nervous system neoplasm	0.000672	0.0023	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—AKT1—peripheral nervous system neoplasm	0.000672	0.0023	CbGpPWpGaD
Auranofin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.000947	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00067	0.000946	CcSEcCtD
Auranofin—IKBKB—Apoptosis—TP53—peripheral nervous system neoplasm	0.000664	0.00227	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—peripheral nervous system neoplasm	0.000659	0.00225	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000656	0.00225	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000906	CcSEcCtD
Auranofin—IKBKB—Immune System—CD55—peripheral nervous system neoplasm	0.000632	0.00216	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—peripheral nervous system neoplasm	0.000629	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—peripheral nervous system neoplasm	0.000623	0.00213	CbGpPWpGaD
Auranofin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00088	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.000875	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000614	0.0021	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000601	0.00206	CbGpPWpGaD
Auranofin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000599	0.000847	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000595	0.00204	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000591	0.00202	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—peripheral nervous system neoplasm	0.000582	0.00199	CbGpPWpGaD
Auranofin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000819	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000579	0.00198	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000566	0.00194	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—peripheral nervous system neoplasm	0.000561	0.00192	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000561	0.00192	CbGpPWpGaD
Auranofin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000783	CcSEcCtD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000553	0.00189	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000552	0.00189	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.000551	0.00189	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000549	0.00188	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000542	0.00185	CbGpPWpGaD
Auranofin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000761	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000758	CcSEcCtD
Auranofin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000755	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000754	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000531	0.00182	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000531	0.00182	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000521	0.00178	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	0.000519	0.00178	CbGpPWpGaD
Auranofin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000503	0.000711	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000501	0.00172	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.0005	0.00171	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000499	0.00171	CbGpPWpGaD
Auranofin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000704	CcSEcCtD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000497	0.0017	CbGpPWpGaD
Auranofin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000698	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000698	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000482	0.00165	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00048	0.00164	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD34—peripheral nervous system neoplasm	0.000479	0.00164	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000478	0.00164	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.000658	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000464	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000461	0.00158	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000443	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000428	0.00147	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000426	0.00146	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000426	0.00146	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000413	0.00141	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000409	0.0014	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NCAM1—peripheral nervous system neoplasm	0.000407	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000389	0.00133	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000381	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—peripheral nervous system neoplasm	0.000379	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000375	0.00128	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000373	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000367	0.00125	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000364	0.00125	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.00035	0.0012	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—peripheral nervous system neoplasm	0.000335	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000331	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000326	0.00112	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000324	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000324	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000323	0.00111	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000322	0.0011	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000322	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNB1—peripheral nervous system neoplasm	0.00032	0.00109	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00031	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000309	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000309	0.00106	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000299	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000298	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000297	0.00102	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000286	0.000979	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000281	0.000961	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	0.000269	0.000922	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000261	0.000894	CbGpPWpGaD
Auranofin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	0.000258	0.000884	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	0.000249	0.000851	CbGpPWpGaD
Auranofin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	0.000249	0.000851	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HGF—peripheral nervous system neoplasm	0.000247	0.000845	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000244	0.000836	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.000242	0.00083	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000238	0.000816	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000235	0.000803	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000226	0.000774	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000224	0.000766	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000222	0.000759	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.00021	0.00072	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000191	0.000656	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000186	0.000636	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000182	0.000625	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000181	0.000621	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPN11—peripheral nervous system neoplasm	0.00018	0.000616	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000178	0.000611	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000167	0.000573	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	0.000163	0.000559	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—peripheral nervous system neoplasm	0.000142	0.000487	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	0.000138	0.000472	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000137	0.000468	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000136	0.000465	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000132	0.00045	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	0.000131	0.000447	CbGpPWpGaD
Auranofin—ALB—Metabolism—TH—peripheral nervous system neoplasm	0.00013	0.000444	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.00012	0.000411	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000116	0.000398	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	0.000115	0.000395	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000109	0.000373	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—peripheral nervous system neoplasm	0.000108	0.00037	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	0.000106	0.000362	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000104	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.2e-05	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.35e-05	0.000286	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	8.34e-05	0.000286	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	7.98e-05	0.000273	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—peripheral nervous system neoplasm	7.92e-05	0.000271	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	7.05e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7e-05	0.00024	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—peripheral nervous system neoplasm	6.99e-05	0.000239	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.52e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.35e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.12e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.52e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	2.86e-05	9.78e-05	CbGpPWpGaD
